Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

NCT00827359 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beth Israel Deaconess Medical Center

Collaborators